BioSpace News Archive

It missed the primary endpoint by a narrow margin—so narrow, in fact, it comes to about a single patient.

Researchers from the Keck School of Medicine of the University of Southern California developed a new nanoparticle technique that “lights up” the unstable calcifications (plaque) that can cause heart attacks and strokes.

To date, the investment firm has raised more than $1 billion to invest in drug development companies.

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act (cited as the Lower Drug Costs Now Act of 2019), awaits a vote by the House in December.

Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced the details for its upcoming event for the investment community, that will follow its oral presentation at the 2019 San Antonio Breast Cancer Symposium (SABCS).

Immune cell type specific profiles correlate with traditional blood cell count method

GenSight Biologics reported results from the REALITY registry study and an analysis of REVERSE and RESCUE Phase III data, which further highlight the poor prognosis for patients with loss of vision due to Leber Hereditary Optic Neuropathy associated with the ND4 mutation.

Nanjing Jiangbei New Area, a state-level new area in East China’s Jiangsu Province, is committed to building a 100 billion-yuan level life and health industrial cluster and becoming a gene city in China.

BT-001 is a novel Invir.IO® based oncolytic virus expressing a Treg-depleting anti-CTLA4 antibody and the cytokine GM-CSF

CommonSpirit Health, a $29 billion nonprofit health system serving 21 states, today announced a partnership with Notable Health that will improve the patient and the provider experience by automating health information collection and making clinical record systems interoperable